Variable | Group A (nā=ā30) | Group B (nā=ā30) | P-Values |
---|---|---|---|
Age | 66.6āĀ±ā6.5 | 66.5āĀ±ā8.1 | 0.986 |
Gender (female/male) | 22/8 | 27/3 | 0.095 |
Height (cm) | 158.8āĀ±ā7.5 | 159.0āĀ±ā7.7 | 0.919 |
Weight (kg) | 66.3āĀ±ā8.8 | 67.6āĀ±ā11.2 | 0.601 |
BMI (kg/m2) | 26.4āĀ±ā4.1 | 26.7āĀ±ā4.0 | 0.756 |
ASA physical status (class I/II) | 12/18 | 15/15 | 0.436 |
CFNB performance | |||
āSide (left/right) | 14/16 | 10/20 | 0.292 |
āin PACU (preā/post-op) | 11/12 | 12/11 | 0.768 |
āin OR (preā/post-op) | 6/1 | 7/0 | 1.000 |
Dosage of spinal bupivacaine (mg) | 12.5 (12.5, 12.5) | 12.5 (12.5, 12.5) | 0.729 |
Upper thoracic sensory block level before surgery | 10 (8, 10) | 10 (8, 10) | 0.629 |
Upper thoracic sensory block level immediately after surgery | 10 (10, 10) | 10 (10, 11) | 0.564 |
Tourniquet application time (min) | 62.1āĀ±ā13.8 | 69.0āĀ±ā14.7 | 0.349 |
Intraoperative blood loss (ml) | 5 (5, 15) | 10 (5, 20) | 0.769 |
Duration of surgery (min) | 74.3āĀ±ā18.4 | 74.1āĀ±ā18.1 | 0.972 |